It was disclosed that IL-1β could enhance the tumor protein 63 (TP63) isoform ΔNP63α, a chemoresistance-associated gene, adding to the cisplatin acquired resistance in breast cancer cells (138). Here, IL1B is linked to breast carcinoma.